Show simple item record

dc.contributor.authorDrinkwater, Nyssa
dc.contributor.authorVu, Hoan
dc.contributor.authorLovell, Kimberly M
dc.contributor.authorCriscione, Kevin R
dc.contributor.authorCollins, Brett M
dc.contributor.authorPrisinzano, Thomas E
dc.contributor.authorPoulsen, Sally-Ann
dc.contributor.authorMcLeish, Michael J
dc.contributor.authorGrunewald, Gary L
dc.contributor.authorMartin, Jennifer L
dc.date.accessioned2017-05-03T11:45:35Z
dc.date.available2017-05-03T11:45:35Z
dc.date.issued2010
dc.date.modified2011-02-14T09:13:09Z
dc.identifier.issn0264-6021
dc.identifier.doi10.1042/BJ20100651
dc.identifier.urihttp://hdl.handle.net/10072/36145
dc.description.abstractCNS (central nervous system) adrenaline (epinephrine) is implicated in a wide range of physiol. and pathol. conditions. PNMT (phenylethanolamine N-methyltransferase) catalyzes the final step in the biosynthesis of adrenaline, the conversion of noradrenaline (norepinephrine) to adrenaline by methylation. To help elucidate the role of CNS adrenaline, and to develop potential drug leads, potent, selective and CNS-active inhibitors are required. The fragment screening approach has advantages over other lead discovery methods including high hit rates, more efficient hits and the ability to sample chem. diversity more easily. In the present study we applied fragment-based screening approaches to the enzyme PNMT. We used crystallog. as the primary screen and identified 12 hits from a small com. library of 384 drug-like fragments. The hits include nine chems. with two fused rings and three single-ring chem. systems. Eight of the hits come from three chem. classes: benzimidazoles (a known class of PNMT inhibitor), purines and quinolines. Nine of the hits have measurable binding affinities (.apprx.5-700 .mu.M) as detd. by isothermal titrn. calorimetry and all nine have ligand efficiencies of 0.39 kcal/mol per heavy atom or better (1 kcal4.184 kJ). We synthesized five elaborated benzimidazole compds. and characterized their binding to PNMT, showing for the first time how this class of inhibitors interact with the noradrenaline-binding site. Finally, we performed a pilot study with PNMT for fragment-based screening by MS showing that this approach could be used as a fast and efficient first-pass screening method prior to characterization of binding mode and affinity of hits.
dc.description.peerreviewedYes
dc.description.publicationstatusYes
dc.languageEnglish
dc.language.isoen_AU
dc.publisherPortland Press Ltd
dc.publisher.placeUnited Kingdom
dc.relation.ispartofstudentpublicationN
dc.relation.ispartofpagefrom51
dc.relation.ispartofpageto61
dc.relation.ispartofissue1
dc.relation.ispartofjournalBiochemical Journal
dc.relation.ispartofvolume431
dc.rights.retentionY
dc.subject.fieldofresearchMedicinal and Biomolecular Chemistry not elsewhere classified
dc.subject.fieldofresearchBiological Sciences
dc.subject.fieldofresearchMedical and Health Sciences
dc.subject.fieldofresearchChemical Sciences
dc.subject.fieldofresearchcode030499
dc.subject.fieldofresearchcode06
dc.subject.fieldofresearchcode11
dc.subject.fieldofresearchcode03
dc.titleFragment-based screening by X-ray crystallography, MS and isothermal titration calorimetry to identify PNMT (phenylethanolamine N-methyltransferase) inhibitors
dc.typeJournal article
dc.type.descriptionC1 - Articles
dc.type.codeC - Journal Articles
gro.date.issued2010
gro.hasfulltextNo Full Text
gro.griffith.authorPoulsen, Sally-Ann
gro.griffith.authorVu, Hoan T.
gro.griffith.authorMartin, Jennifer


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

  • Journal articles
    Contains articles published by Griffith authors in scholarly journals.

Show simple item record